54,958 XNAS Volume
XNAS 25 Mar, 2025 1:44 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Deepika Jalota | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Michael Carulli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 265,000 | 265,000 | - | - | Employee Stock Option (right to buy) | |
| Deepika Jalota | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.50 per share. | 11 Sep 2024 | 7,218 | 118,283 | - | 1.5 | 10,853 | Common Stock |
| Michael Carulli | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.50 per share. | 11 Sep 2024 | 2,891 | 88,395 | - | 1.5 | 4,347 | Common Stock |
| Deepika Jalota | Chief Development Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 125,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Deepika Jalota | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 90,774 | 90,774 | - | - | Employee Stock Option (right to buy) | |
| Deepika Jalota | Chief Development Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 68,100 | 0 | - | - | Employee Stock Option (right to buy) | |
| Deepika Jalota | Chief Development Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 22,674 | 0 | - | - | Employee Stock Option (right to buy) | |
| Deepika Jalota | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| Michael Carulli | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Michael Carulli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 40,805 | 40,805 | - | - | Employee Stock Option (right to buy) | |
| Michael Carulli | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 27,200 | 0 | - | - | Employee Stock Option (right to buy) | |
| Michael Carulli | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 13,605 | 0 | - | - | Employee Stock Option (right to buy) | |
| Michael Carulli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 67,500 | 67,500 | - | - | Stock Option (right to buy) | |
| Carol G. Gallagher | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jun 2024 | 67,500 | 67,500 | - | - | Stock Option (right to buy) | |
| Carol G. Gallagher | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jun 2024 | 67,500 | 0 | - | - | Stock Option (right to buy) | |
| Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 67,500 | 67,500 | - | - | Stock Option (right to buy) | |
| Charles M. Baum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 67,500 | 67,500 | - | - | Stock Option (right to buy) | |
| Laurie D. Stelzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 67,500 | 67,500 | - | - | Stock Option (right to buy) | |
| Kirsten Flowers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 67,500 | 67,500 | - | - | Stock Option (right to buy) | |
| Jalota Deepika | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 225,095 | 225,095 | - | - | Employee Stock Option (right to buy) | |
| Carulli Michael | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 82,220 | 91,286 | - | 0 | Common Stock | |
| Carulli Michael | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 204,630 | 204,630 | - | - | Employee Stock Option (right to buy) | |
| Jalota Deepika | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 95,555 | 125,501 | - | 0 | Common Stock | |
| Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 21,500 | 21,500 | - | - | Stock Option (right to buy) | |
| Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 21,500 | 21,500 | - | - | Stock Option (right to buy) | |
| Carol G. Gallagher | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jun 2023 | 21,500 | 21,500 | - | - | Stock Option (right to buy) | |
| Carol G. Gallagher | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jun 2023 | 21,500 | 0 | - | - | Stock Option (right to buy) | |
| Charles M. Baum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 21,500 | 21,500 | - | - | Stock Option (right to buy) | |
| Laurie D. Stelzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 21,500 | 21,500 | - | - | Stock Option (right to buy) | |
| Kirsten Flowers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 21,500 | 21,500 | - | - | Stock Option (right to buy) | |
| Winston Kung | COO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | |
| Leila Alland | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Deepika Jalota | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| Winston Kung | COO, CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2022 | 2,560 | 10,600 | - | 0 | Common Stock | |
| Carol G. Gallagher | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Nov 2022 | 39,000 | 39,000 | - | - | Stock Option (right to buy) | |
| Carol G. Gallagher | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Nov 2022 | 39,000 | 39,000 | - | - | Stock Option (right to buy) | |
| Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2022 | 39,000 | 39,000 | - | - | Stock Option (right to buy) | |
| Leila Alland | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2022 | 52,200 | 52,200 | - | 0 | Common Stock | |
| Deepika Jalota | SVP, Regulatory Affairs and QA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2022 | 34,050 | 34,050 | - | 0 | Common Stock | |
| Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 19,500 | 19,500 | - | - | Stock option (right to buy) | |
| Laurie D. Stelzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 19,500 | 19,500 | - | - | Stock Option | |
| Kirsten Flowers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 19,500 | 19,500 | - | - | Stock Option (right to buy) | |
| Winston Kung | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2022 | 4,000 | 210,034 | - | - | Stock Option (right to buy) | |
| Winston Kung | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. | 20 Apr 2022 | 4,000 | 10,600 | - | 3.2 | 12,880 | Common Stock |
| Winston Kung | COO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 104,400 | 104,400 | - | - | Employee Stock Option (right to buy) | |
| Leila Alland | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 104,400 | 104,400 | - | - | Employee Stock Option (right to buy) | |
| Deepika Jalota | SVP, Regulatory Affairs and QA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 68,100 | 68,100 | - | - | Employee Stock Option (right to buy) | |
| Kirsten Flowers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2022 | 32,677 | 32,677 | - | - | Stock Option (right to buy) | |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.15 per share. | 06 Oct 2021 | 800 | 1,101,283 | - | 30.2 | 24,120 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.08 per share. | 30 Sep 2021 | 100 | 1,102,083 | - | 30.1 | 3,008 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.10 per share. | 30 Sep 2021 | 11,541 | 1,102,183 | - | 30.1 | 347,384 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.03 per share. | 30 Sep 2021 | 2,978 | 1,113,724 | - | 30.0 | 89,429 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.11 per share. | 27 Sep 2021 | 1,753 | 1,122,410 | - | 30.1 | 52,783 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.04 per share. | 27 Sep 2021 | 5,708 | 1,116,702 | - | 30.0 | 171,468 | Common Stock |
| Arnold J. Levine | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 22 Sep 2021 | 3,500 | 409,842 | - | 30 | 105,000 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 22 Sep 2021 | 100 | 1,124,163 | - | 30 | 3,000 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.03 per share. | 17 Sep 2021 | 711 | 1,124,263 | - | 30.0 | 21,351 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.44 per share. | 09 Sep 2021 | 38,056 | 1,143,417 | - | 30.4 | 1,158,425 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.20 per share. | 09 Sep 2021 | 13,272 | 1,124,974 | - | 30.2 | 400,814 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 31.03 per share. | 09 Sep 2021 | 5,171 | 1,138,246 | - | 31.0 | 160,456 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.31 per share. | 09 Sep 2021 | 14,329 | 1,181,473 | - | 30.3 | 434,312 | Common Stock |
| Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.25 per share. | 09 Sep 2021 | 100 | 0 | - | 30.3 | 3,025 | Common Stock |
| Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2021 | 100 | 353,850 | - | - | Employee Stock Option (right to buy) | |
| Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 09 Sep 2021 | 100 | 100 | - | 3.9 | 390 | Common Stock |
| Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.25 per share. | 07 Sep 2021 | 3,900 | 0 | - | 30.3 | 117,975 | Common Stock |
| Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 3,900 | 353,950 | - | - | Employee Stock Option (right to buy) | |
| Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 07 Sep 2021 | 3,900 | 3,900 | - | 3.9 | 15,210 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.38 per share. | 31 Aug 2021 | 21,986 | 1,201,202 | - | 30.4 | 667,935 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.15 per share. | 31 Aug 2021 | 5,400 | 1,195,802 | - | 30.2 | 162,810 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.12 per share. | 31 Aug 2021 | 19,520 | 1,223,188 | - | 30.1 | 587,942 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 31.13 per share. | 26 Aug 2021 | 6,091 | 1,280,383 | - | 31.1 | 189,613 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.05 per share. | 26 Aug 2021 | 13,233 | 1,242,708 | - | 30.1 | 397,652 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 31.06 per share. | 26 Aug 2021 | 1,045 | 1,255,941 | - | 31.1 | 32,458 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.50 per share. | 26 Aug 2021 | 23,397 | 1,256,986 | - | 30.5 | 713,609 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.39 per share. | 26 Aug 2021 | 15,063 | 1,286,474 | - | 30.4 | 457,765 | Common Stock |
| Arnold J. Levine | Director | Sale of securities on an exchange or to another person at price $ 29.50 per share. | 23 Aug 2021 | 3,500 | 413,342 | - | 29.5 | 103,250 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 31.01 per share. | 23 Aug 2021 | 13,526 | 1,585,953 | - | 31.0 | 419,441 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 31.08 per share. | 23 Aug 2021 | 14,490 | 1,599,479 | - | 31.1 | 450,349 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 31.06 per share. | 23 Aug 2021 | 700 | 1,613,969 | - | 31.1 | 21,742 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.66 per share. | 23 Aug 2021 | 23,138 | 1,614,669 | - | 30.7 | 709,411 | Common Stock |
| Winston Kung | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. | 19 Aug 2021 | 5,000 | 6,600 | - | 3.2 | 16,100 | Common Stock |
| Winston Kung | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2021 | 5,000 | 214,034 | - | - | Stock Option (right to buy) | |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.97 per share. | 18 Aug 2021 | 3,800 | 1,637,807 | - | 31.0 | 117,686 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 32.57 per share. | 18 Aug 2021 | 11,431 | 1,657,040 | - | 32.6 | 372,308 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 34.32 per share. | 18 Aug 2021 | 2,237 | 1,641,607 | - | 34.3 | 76,774 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 33.84 per share. | 18 Aug 2021 | 13,196 | 1,643,844 | - | 33.8 | 446,553 | Common Stock |
| Deepika Jalota | SVP, Regulatory Affairs and QA | Sale of securities on an exchange or to another person at price $ 33.78 per share. | 17 Aug 2021 | 2,896 | 0 | - | 33.8 | 97,814 | Common Stock |
| Deepika Jalota | SVP, Regulatory Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2021 | 2,896 | 87,320 | - | - | Stock option (right to buy) | |
| Deepika Jalota | SVP, Regulatory Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.53 per share. | 17 Aug 2021 | 2,896 | 2,896 | - | 3.5 | 10,223 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 34.66 per share. | 13 Aug 2021 | 1,500 | 1,721,676 | - | 34.7 | 51,990 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 33.93 per share. | 13 Aug 2021 | 15,746 | 1,668,471 | - | 33.9 | 534,262 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 33.21 per share. | 13 Aug 2021 | 15,276 | 1,684,217 | - | 33.2 | 507,316 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 34.54 per share. | 13 Aug 2021 | 2,599 | 1,699,493 | - | 34.5 | 89,769 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 33.80 per share. | 13 Aug 2021 | 19,584 | 1,702,092 | - | 33.8 | 661,939 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 34.22 per share. | 13 Aug 2021 | 25,786 | 1,723,176 | - | 34.2 | 882,397 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 35.54 per share. | 10 Aug 2021 | 2,600 | 1,796,937 | - | 35.5 | 92,404 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 34.83 per share. | 10 Aug 2021 | 1,971 | 1,748,962 | - | 34.8 | 68,650 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 34.35 per share. | 10 Aug 2021 | 11,565 | 1,750,933 | - | 34.4 | 397,258 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 34.04 per share. | 10 Aug 2021 | 34,439 | 1,762,498 | - | 34.0 | 1,172,304 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 34.76 per share. | 10 Aug 2021 | 17,905 | 1,799,537 | - | 34.8 | 622,378 | Common Stock |
| Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.66 per share. | 09 Aug 2021 | 2,049 | 224 | - | 32.7 | 66,914 | Common Stock |
| Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 4,000 | 357,850 | - | - | Employee Stock Option (right to buy) | |
| Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 36.69 per share. | 09 Aug 2021 | 224 | 0 | - | 36.7 | 8,219 | Common Stock |
| Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.06 per share. | 09 Aug 2021 | 2,198 | 1,802 | - | 35.1 | 77,070 | Common Stock |
| Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 09 Aug 2021 | 4,000 | 4,000 | - | 3.9 | 15,600 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 36.38 per share. | 05 Aug 2021 | 26,871 | 1,868,264 | - | 36.4 | 977,567 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 36.64 per share. | 05 Aug 2021 | 300 | 1,817,442 | - | 36.6 | 10,992 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 36.08 per share. | 05 Aug 2021 | 8,623 | 1,817,742 | - | 36.1 | 311,118 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 35.14 per share. | 05 Aug 2021 | 13,259 | 1,826,365 | - | 35.1 | 465,921 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 36.94 per share. | 05 Aug 2021 | 200 | 1,839,624 | - | 36.9 | 7,388 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 36.61 per share. | 05 Aug 2021 | 19,700 | 1,839,824 | - | 36.6 | 721,217 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 36.70 per share. | 05 Aug 2021 | 8,740 | 1,859,524 | - | 36.7 | 320,758 | Common Stock |
| Winston Kung | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. | 03 Aug 2021 | 4,500 | 6,100 | - | 3.2 | 14,490 | Common Stock |
| Winston Kung | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2021 | 4,500 | 219,034 | - | - | Stock Option (right to buy) | |
| Winston Kung | COO, CFO | Sale of securities on an exchange or to another person at price $ 33.82 per share. | 03 Aug 2021 | 4,500 | 1,600 | - | 33.8 | 152,178 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 35.10 per share. | 02 Aug 2021 | 17,175 | 1,929,060 | - | 35.1 | 602,843 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 36.80 per share. | 02 Aug 2021 | 5,249 | 1,895,135 | - | 36.8 | 193,163 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 36.22 per share. | 02 Aug 2021 | 28,676 | 1,900,384 | - | 36.2 | 1,038,645 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 34.21 per share. | 02 Aug 2021 | 1,760 | 1,946,235 | - | 34.2 | 60,210 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 34.74 per share. | 02 Aug 2021 | 100 | 1,947,995 | - | 34.7 | 3,474 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 33.80 per share. | 02 Aug 2021 | 30,145 | 1,948,095 | - | 33.8 | 1,018,901 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 34.74 per share. | 02 Aug 2021 | 13,031 | 1,978,240 | - | 34.7 | 452,697 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 35.76 per share. | 28 Jul 2021 | 8,724 | 1,993,571 | - | 35.8 | 311,970 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 35.73 per share. | 28 Jul 2021 | 2,300 | 1,991,271 | - | 35.7 | 82,179 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 35.73 per share. | 23 Jul 2021 | 4,839 | 2,002,830 | - | 35.7 | 172,897 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 36.00 per share. | 23 Jul 2021 | 11,988 | 2,007,669 | - | 36 | 431,568 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 35.61 per share. | 23 Jul 2021 | 535 | 2,002,295 | - | 35.6 | 19,051 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 35.61 per share. | 21 Jul 2021 | 200 | 2,019,657 | - | 35.6 | 7,122 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 35.82 per share. | 21 Jul 2021 | 18,672 | 2,019,857 | - | 35.8 | 668,831 | Common Stock |
| Winston Kung | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2021 | 4,500 | 223,534 | - | - | Stock Option (right to buy) | |
| Winston Kung | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. | 08 Jul 2021 | 4,500 | 6,100 | - | 3.2 | 14,490 | Common Stock |
| Winston Kung | COO, CFO | Sale of securities on an exchange or to another person at price $ 33.75 per share. | 08 Jul 2021 | 4,500 | 1,600 | - | 33.8 | 151,875 | Common Stock |
| Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.93 per share. | 07 Jul 2021 | 1,951 | 2,049 | - | 31.9 | 62,300 | Common Stock |
| Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.66 per share. | 07 Jul 2021 | 2,049 | 0 | - | 32.7 | 66,914 | Common Stock |
| Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 07 Jul 2021 | 4,000 | 4,000 | - | 3.9 | 15,600 | Common Stock |
| Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2021 | 4,000 | 361,850 | - | - | Employee Stock Option (right to buy) | |
| Arnold J. Levine | Director | Sale of securities on an exchange or to another person at price $ 33.22 per share. | 21 Jun 2021 | 3,389 | 420,453 | - | 33.2 | 112,579 | Common Stock |
| Arnold J. Levine | Director | Sale of securities on an exchange or to another person at price $ 34.08 per share. | 21 Jun 2021 | 111 | 420,342 | - | 34.1 | 3,783 | Common Stock |
| Winston Kung | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. | 04 Jun 2021 | 4,500 | 6,100 | - | 3.2 | 14,490 | Common Stock |
| Winston Kung | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2021 | 4,500 | 228,034 | - | - | Stock Option (right to buy) | |
| Winston Kung | COO, CFO | Sale of securities on an exchange or to another person at price $ 33.75 per share. | 04 Jun 2021 | 4,500 | 1,600 | - | 33.8 | 151,875 | Common Stock |
| Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 16,333 | 16,333 | - | - | Stock option (right to buy) | |
| Laurie D. Stelzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 16,333 | 16,333 | - | - | Stock Option | |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 35.80 per share. | 28 May 2021 | 5,100 | 2,038,529 | - | 35.8 | 182,580 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 35.66 per share. | 25 May 2021 | 7,487 | 2,043,629 | - | 35.7 | 266,986 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 35.91 per share. | 25 May 2021 | 8,518 | 2,051,116 | - | 35.9 | 305,881 | Common Stock |
| Arnold J. Levine | Director | Sale of securities on an exchange or to another person at price $ 34.68 per share. | 20 May 2021 | 2,961 | 423,842 | - | 34.7 | 102,676 | Common Stock |
| Arnold J. Levine | Director | Sale of securities on an exchange or to another person at price $ 33.57 per share. | 20 May 2021 | 539 | 426,803 | - | 33.6 | 18,092 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 35.65 per share. | 20 May 2021 | 2,911 | 2,101,503 | - | 35.6 | 103,777 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 35.84 per share. | 20 May 2021 | 19,774 | 2,081,729 | - | 35.8 | 708,700 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 36.03 per share. | 20 May 2021 | 22,095 | 2,059,634 | - | 36.0 | 796,083 | Common Stock |
| Arnold J. Levine | Director | Sale of securities on an exchange or to another person at price $ 35.12 per share. | 12 May 2021 | 3,500 | 416,842 | - | 35.1 | 122,929 | Common Stock |
| Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 5,781 | 5,781 | - | - | Stock Option (right to buy) | |
| Winston Kung | COO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 50,337 | 50,337 | - | - | Employee Stock Option (right to buy) | |
| Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2021 | 4,000 | 365,850 | - | - | Employee Stock Option (right to buy) | |
| Leila Alland | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 36,279 | 36,279 | - | - | Employee Stock Option (right to buy) | |
| Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.00 per share. | 12 May 2021 | 1,367 | 0 | - | 34.0 | 46,484 | Common Stock |
| Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 33.39 per share. | 12 May 2021 | 2,633 | 1,367 | - | 33.4 | 87,903 | Common Stock |
| Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 12 May 2021 | 4,000 | 4,000 | - | 3.9 | 15,600 | Common Stock |
| Deepika Jalota | SVP, Regulatory Affairs and QA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 22,674 | 22,674 | - | - | Employee Stock Option (right to buy) | |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 35.67 per share. | 10 May 2021 | 1,787 | 2,104,414 | - | 35.7 | 63,742 | Common Stock |
| Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.80 per share. | 07 May 2021 | 3,842 | 158 | - | 34.8 | 133,702 | Common Stock |
| Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2021 | 4,000 | 369,850 | - | - | Employee Stock Option (right to buy) | |
| Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.49 per share. | 07 May 2021 | 158 | 0 | - | 35.5 | 5,607 | Common Stock |
| Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 07 May 2021 | 4,000 | 4,000 | - | 3.9 | 15,600 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 35.64 per share. | 05 May 2021 | 600 | 2,106,201 | - | 35.6 | 21,384 | Common Stock |
| Winston Kung | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. | 03 May 2021 | 4,500 | 6,100 | - | 3.2 | 14,490 | Common Stock |
| Winston Kung | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2021 | 4,500 | 232,534 | - | - | Stock Option (right to buy) | |
| Winston Kung | COO, CFO | Sale of securities on an exchange or to another person at price $ 33.75 per share. | 03 May 2021 | 4,500 | 1,600 | - | 33.8 | 151,875 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 34.89 per share. | 09 Apr 2021 | 19,858 | 2,110,704 | - | 34.9 | 692,846 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 33.11 per share. | 09 Apr 2021 | 100 | 2,106,801 | - | 33.1 | 3,311 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 32.00 per share. | 09 Apr 2021 | 900 | 2,106,901 | - | 32 | 28,800 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 31.17 per share. | 09 Apr 2021 | 2,903 | 2,107,801 | - | 31.2 | 90,487 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 33.75 per share. | 09 Apr 2021 | 5,905 | 2,130,562 | - | 33.8 | 199,294 | Common Stock |
| Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 33.86 per share. | 07 Apr 2021 | 3,972 | 28 | - | 33.9 | 134,481 | Common Stock |
| Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2021 | 4,000 | 373,850 | - | - | Employee Stock Option (right to buy) | |
| Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.43 per share. | 07 Apr 2021 | 28 | 0 | - | 34.4 | 964 | Common Stock |
| Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 07 Apr 2021 | 4,000 | 4,000 | - | 3.9 | 15,600 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 34.67 per share. | 06 Apr 2021 | 67,086 | 2,194,246 | - | 34.7 | 2,325,872 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 34.23 per share. | 06 Apr 2021 | 20,701 | 2,136,467 | - | 34.2 | 708,595 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 33.82 per share. | 06 Apr 2021 | 12,621 | 2,157,168 | - | 33.8 | 426,842 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 34.50 per share. | 06 Apr 2021 | 100 | 2,169,789 | - | 34.5 | 3,450 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 33.88 per share. | 06 Apr 2021 | 24,357 | 2,169,889 | - | 33.9 | 825,215 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 33.85 per share. | 06 Apr 2021 | 11,571 | 2,261,332 | - | 33.8 | 391,678 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 33.46 per share. | 01 Apr 2021 | 18,990 | 2,302,106 | - | 33.5 | 635,405 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 34.03 per share. | 01 Apr 2021 | 29,203 | 2,272,903 | - | 34.0 | 993,778 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 32.94 per share. | 01 Apr 2021 | 12,435 | 2,321,096 | - | 32.9 | 409,609 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 33.16 per share. | 29 Mar 2021 | 764 | 2,389,640 | - | 33.2 | 25,334 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 32.93 per share. | 29 Mar 2021 | 13,645 | 2,333,531 | - | 32.9 | 449,330 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 32.33 per share. | 29 Mar 2021 | 18,381 | 2,347,176 | - | 32.3 | 594,258 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 31.19 per share. | 29 Mar 2021 | 1,600 | 2,365,557 | - | 31.2 | 49,904 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 31.19 per share. | 29 Mar 2021 | 3,276 | 2,367,157 | - | 31.2 | 102,178 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 30.82 per share. | 29 Mar 2021 | 19,207 | 2,370,433 | - | 30.8 | 591,960 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 31.60 per share. | 29 Mar 2021 | 1,410 | 2,390,404 | - | 31.6 | 44,556 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 35.12 per share. | 24 Mar 2021 | 19,002 | 2,509,288 | - | 35.1 | 667,350 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 33.44 per share. | 24 Mar 2021 | 35,268 | 2,391,814 | - | 33.4 | 1,179,362 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 34.82 per share. | 24 Mar 2021 | 1,200 | 2,427,082 | - | 34.8 | 41,784 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 34.17 per share. | 24 Mar 2021 | 3,787 | 2,428,282 | - | 34.2 | 129,402 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 32.94 per share. | 24 Mar 2021 | 61,340 | 2,432,069 | - | 32.9 | 2,020,540 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 39.00 per share. | 24 Mar 2021 | 10,100 | 2,493,409 | - | 39 | 393,900 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 37.51 per share. | 24 Mar 2021 | 700 | 2,503,509 | - | 37.5 | 26,257 | Common Stock |
| Thilo Schroeder | Director | Sale of securities on an exchange or to another person at price $ 36.53 per share. | 24 Mar 2021 | 5,079 | 2,504,209 | - | 36.5 | 185,536 | Common Stock |
| Winston Kung | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. | 08 Dec 2020 | 1,600 | 1,600 | - | 3.2 | 5,152 | Common Stock |
| Winston Kung | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2020 | 1,600 | 237,034 | - | - | Stock Option (right to buy) | |
| Thilo Schroeder | Director, Ten Percent Owner | 29 Sep 2020 | 760,267 | 2,528,290 | - | - | Common Stock | ||
| Thilo Schroeder | Director, Ten Percent Owner | 29 Sep 2020 | 1,768,023 | 1,768,023 | - | - | Common Stock | ||
| Thilo Schroeder | Director, Ten Percent Owner | 29 Sep 2020 | 1,768,023 | 0 | - | - | Series C Preferred Stock | ||
| Thilo Schroeder | Director, Ten Percent Owner | 29 Sep 2020 | 760,267 | 0 | - | - | Series D Preferred Stock | ||
| Arnold L. Oronsky | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 25 Sep 2020 | 55,555 | 55,555 | - | 18 | 999,990 | Common Stock |
| Arnold L. Oronsky | Director, Ten Percent Owner | 25 Sep 2020 | 265,203 | 0 | - | - | Series C Preferred Stock | ||
| Arnold L. Oronsky | Director, Ten Percent Owner | 25 Sep 2020 | 1,040,654 | 0 | - | - | Series B Preferred Stock | ||
| Arnold L. Oronsky | Director, Ten Percent Owner | 25 Sep 2020 | 3,488,398 | 0 | - | - | Series A Preferred Stock | ||
| Arnold L. Oronsky | Director, Ten Percent Owner | 25 Sep 2020 | 1,620,101 | 0 | - | - | Series Seed Preferred Stock | ||
| Arnold L. Oronsky | Director, Ten Percent Owner | 25 Sep 2020 | 265,203 | 6,469,911 | - | - | Common Stock | ||
| Arnold L. Oronsky | Director, Ten Percent Owner | 25 Sep 2020 | 1,040,654 | 6,204,708 | - | - | Common Stock | ||
| Arnold L. Oronsky | Director, Ten Percent Owner | 25 Sep 2020 | 3,488,398 | 5,164,054 | - | - | Common Stock | ||
| Arnold L. Oronsky | Director, Ten Percent Owner | 25 Sep 2020 | 1,620,101 | 1,675,656 | - | - | Common Stock |